Valuation Emcure Pharmaceuticals Limited

Stocks

End-of-day quote NSE India S.E. 23/10/2026			5-day change	1st Jan Change
1,770.40 ^INR	-0.68%		-2.76%	+29.75%

10-02	Emcure Pharmaceuticals Limited Receives Income-Tax Department Orders Imposing Aggregate Penalty of INR 577.396732 Million	CI
09-23	Emcure Pharmaceuticals Limited Approves Final Dividend for the Financial Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2025	2026	2027	2028	2029
Market Cap ¹	203,202	302,490	335,810	-	-
Change	-	48.86%	11.02%	-	-
Enterprise Value (EV) ¹	208,106	306,160	342,194	332,532	320,312
Change	-	47.12%	11.77%	-2.82%	-3.67%
P/E	29.4x	32.7x	28.2x	22.8x	19.1x
PBR	4.57x	-	5.51x	4.49x	3.68x
PEG	-	1x	1x	1x	1x
Capitalization / Revenue	2.57x	3.29x	3.17x	2.8x	2.51x
EV / Revenue	2.64x	3.33x	3.23x	2.78x	2.39x
EV / EBITDA	14.2x	17.1x	15.8x	13.1x	11x
EV / EBIT	19.2x	22.3x	20.1x	16.2x	13.3x
EV / FCF	33x	52.5x	34.6x	28.1x	21.5x
FCF Yield	3.03%	1.9%	2.89%	3.56%	4.65%
Dividend per Share ²	3	3.6	4.007	4.728	5.773
Rate of return	0.28%	0.23%	0.23%	0.27%	0.33%
EPS ²	36.43	48.77	62.72	77.66	92.93
Distribution rate	8.23%	7.38%	6.39%	6.09%	6.21%
Net sales ¹	78,960	92,035	106,051	119,824	133,996
EBITDA ¹	14,689	17,890	21,618	25,428	29,101
EBIT ¹	10,847	13,740	17,017	20,571	24,113
Net income ¹	6,813	9,244	11,895	14,608	17,577
Net Debt ¹	4,904	3,670	6,384	-3,278	-15,498
Reference price ²	1,072.40	1,595.50	1,770.40	1,770.40	1,770.40
Nbr of stocks (in thousands)	189,483	189,590	189,680	-	-
Announcement Date	22/05/25	05/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
EMCURE PHARMACEUTICALS LIMITED	28.23x	3.23x	15.83x	0.23%	3.54B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.37x	6.66x	18.41x	1.93%	400.72B
Weighted average by Cap.	35.22x	8.29x	20.39x	1.8%